FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 294:241-245 January 29, 1976 Number 5 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

To assess the influence of diabetes mellitus on bone metabolism, we measured skeletal mass in the forearms of 35 patients with juvenile diabetes on insulin and 101 stable patients with adult-onset diabetes, on diet alone, insulin, or oral hypoglycemic agents. There was a significant loss of bone mass in both juvenile and adult-onset diabetes (P less than 0.01) as compared to controls matched for age and sex. The decrease was already present in patients with diabetes of less than five years' duration. Bone loss and duration of the diabetes did not correlate; the greatest decrease in bone mass was observed in the patients receiving oral agents. These data are consistent with the hypothesis that the loss of skeletal tissue in diabetes reflects the underlying disease since it occurs early and is not related to severity as evidenced by the need for insulin, to duration, or to treatment with insulin or diet alone.

This article has been cited by other articles:

• Gaston, M. S., Simpson, A. H. R. W. (2007). Inhibition of fracture healing. J Bone Joint Surg Br 89-B: 1553-1560 [Abstract] [Full Text]  
• Zhong, Q., Itokawa, T., Sridhar, S., Ding, K.-H., Xie, D., Kang, B., Bollag, W. B., Bollag, R. J., Hamrick, M., Insogna, K., Isales, C. M. (2007). Effects of glucose-dependent insulinotropic peptide on osteoclast function. Am. J. Physiol. Endocrinol. Metab. 292: E543-E548 [Abstract] [Full Text]  
• Botolin, S., McCabe, L. R. (2007). Bone Loss and Increased Bone Adiposity in Spontaneous and Pharmacologically Induced Diabetic Mice. Endocrinology 148: 198-205 [Abstract] [Full Text]  
• Irwin, R., Lin, H. V., Motyl, K. J., McCabe, L. R. (2006). Normal Bone Density Obtained in the Absence of Insulin Receptor Expression in Bone. Endocrinology 147: 5760-5767 [Abstract] [Full Text]  
• Leger, J., Marinovic, D., Alberti, C., Dorgeret, S., Chevenne, D., Marchal, C. L., Tubiana-Rufi, N., Sebag, G., Czernichow, P. (2006). Lower Bone Mineral Content in Children with Type 1 Diabetes Mellitus Is Linked to Female Sex, Low Insulin-Like Growth Factor Type I Levels, and High Insulin Requirement. J. Clin. Endocrinol. Metab. 91: 3947-3953 [Abstract] [Full Text]  
• Fleischli, J. G., Laughlin, T. J., Athanasiou, K., Lanctot, D. R., Lavery, L., Wang, X., Agrawal, C. M. (2006). Effect of diabetes mellitus on the material properties of the distal tibia.. J. Am. Podiatr. Med. Assoc. 96: 91-95 [Abstract] [Full Text]  
• Kloting, N., Follak, N., Kloting, I. (2005). Is there an autoimmune process in bone? Gene expression studies in diabetic and nondiabetic BB rats as well as BB rat-related and -unrelated rat strains. Physiol. Genomics 24: 59-64 [Abstract] [Full Text]  
• Galluzzi, F., Stagi, S., Salti, R., Toni, S., Piscitelli, E., Simonini, G., Falcini, F., Chiarelli, F. (2005). Osteoprotegerin serum levels in children with type 1 diabetes: a potential modulating role in bone status. Eur J Endocrinol 153: 879-885 [Abstract] [Full Text]  
• Botolin, S., Faugere, M.-C., Malluche, H., Orth, M., Meyer, R., McCabe, L. R. (2005). Increased Bone Adiposity and Peroxisomal Proliferator-Activated Receptor-{gamma}2 Expression in Type I Diabetic Mice. Endocrinology 146: 3622-3631 [Abstract] [Full Text]  
• Davies, M. R., Lund, Richard. J., Mathew, S., Hruska, K. A. (2005). Low Turnover Osteodystrophy and Vascular Calcification Are Amenable to Skeletal Anabolism in an Animal Model of Chronic Kidney Disease and the Metabolic Syndrome. J. Am. Soc. Nephrol. 16: 917-928 [Abstract] [Full Text]  
• Aris, R. M., Merkel, P. A., Bachrach, L. K., Borowitz, D. S., Boyle, M. P., Elkin, S. L., Guise, T. A., Hardin, D. S., Haworth, C. S., Holick, M. F., Joseph, P. M., O'Brien, K., Tullis, E., Watts, N. B., White, T. B. (2005). Guide to Bone Health and Disease in Cystic Fibrosis. J. Clin. Endocrinol. Metab. 90: 1888-1896 [Abstract] [Full Text]  
• Abedin, M., Tintut, Y., Demer, L. L. (2004). Vascular Calcification: Mechanisms and Clinical Ramifications. Arterioscler. Thromb. Vasc. Bio. 24: 1161-1170 [Abstract] [Full Text]  
• Dacquin, R., Davey, R. A., Laplace, C., Levasseur, R., Morris, H. A., Goldring, S. R., Gebre-Medhin, S., Galson, D. L., Zajac, J. D., Karsenty, G. (2004). Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo. J. Cell Biol. 164: 509-514 [Abstract] [Full Text]  
• Brown, S. A., Sharpless, J. L. (2004). Osteoporosis: An Under-appreciated Complication of Diabetes. Clin. Diabetes 22: 10-20 [Abstract] [Full Text]  
• He, H., Liu, R., Desta, T., Leone, C., Gerstenfeld, L. C., Graves, D. T. (2004). Diabetes Causes Decreased Osteoclastogenesis, Reduced Bone Formation, and Enhanced Apoptosis of Osteoblastic Cells in Bacteria Stimulated Bone Loss. Endocrinology 145: 447-452 [Abstract] [Full Text]  
• RYAN, M. E., CARNU, O., KAMER, A. (2003). The influence of diabetes on the periodontal tissues. Journal of the American Dental Association 134: 34S-40S [Abstract] [Full Text]  
• Santana, R. B., Xu, L., Chase, H. B., Amar, S., Graves, D. T., Trackman, P. C. (2003). A Role for Advanced Glycation End Products in Diminished Bone Healing in Type 1 Diabetes. Diabetes 52: 1502-1510 [Abstract] [Full Text]  
• Lu, H., Kraut, D., Gerstenfeld, L. C., Graves, D. T. (2003). Diabetes Interferes with the Bone Formation by Affecting the Expression of Transcription Factors that Regulate Osteoblast Differentiation. Endocrinology 144: 346-352 [Abstract] [Full Text]  
• Zayzafoon, M., Botolin, S., McCabe, L. R. (2002). p38 and Activating Transcription Factor-2 Involvement in Osteoblast Osmotic Response to Elevated Extracellular Glucose. J. Biol. Chem. 277: 37212-37218 [Abstract] [Full Text]  
• Nicodemus, K. K., Folsom, A. R. (2001). Type 1 and Type 2 Diabetes and Incident Hip Fractures in Postmenopausal Women. Diabetes Care 24: 1192-1197 [Abstract] [Full Text]  
• Mailhot, G., Petit, J.-L., Demers, C., Gascon-Barre, M. (2000). Influence of the in Vivo Calcium Status on Cellular Calcium Homeostasis and the Level of the Calcium-Binding Protein Calreticulin in Rat Hepatocytes. Endocrinology 141: 891-900 [Abstract] [Full Text]  
• Lien, Y., Stern, R, Fu, J., Siegel, R. (1984). Inhibition of collagen fibril formation in vitro and subsequent cross-linking by glucose. Science 225: 1489-1491 [Abstract]  
• Norman, A., Frankel, J., Heldt, A., Grodsky, G. (1980). Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 209: 823-825 [Abstract]  
• Schneider, L., Schedl, H., McCain, T, Haussler, M. (1977). Experimental diabetes reduces circulating 1,25-dihydroxyvitamin D in the rat. Science 196: 1452-1454 [Abstract]